Platinum Partners Value Arbitrage Fund, Ltd. Partnership v. Chicago Board Options Exchange

2018 IL App (1st) 171316, 105 N.E.3d 160
CourtAppellate Court of Illinois
DecidedMarch 29, 2018
Docket1-17-1316
StatusUnpublished
Cited by1 cases

This text of 2018 IL App (1st) 171316 (Platinum Partners Value Arbitrage Fund, Ltd. Partnership v. Chicago Board Options Exchange) is published on Counsel Stack Legal Research, covering Appellate Court of Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Platinum Partners Value Arbitrage Fund, Ltd. Partnership v. Chicago Board Options Exchange, 2018 IL App (1st) 171316, 105 N.E.3d 160 (Ill. Ct. App. 2018).

Opinion

JUSTICE GORDON delivered the judgment of the court, with opinion.

¶ 1 In the case at bar, the trial court denied a motion for summary judgment by defendant Chicago Board Options Exchange (CBOE) but granted summary judgment for defendant Options Clearing Corporation (OCC). Although this suit continues below, we have jurisdiction to hear this appeal, since the trial court entered a finding pursuant to Illinois Supreme Court Rule 304(a) ( Ill. S. Ct. R. 304(a) (eff. March 8, 2016) ) that there was no just reason to delay the appeal of the summary judgment granted in favor of defendant OCC.

¶ 2 This court previously reviewed this same case, when the trial court previously dismissed it on the ground that defendants were shielded from suit under the doctrine of regulatory immunity. Platinum Partners Value Arbitrage Fund, Ltd. Partnership v. Chicago Board Options Exchange , 2012 IL App (1st) 112903 , ¶ 2, 364 Ill.Dec. 137 , 976 N.E.2d 415 . This court reversed the trial court's dismissal, stating: "Where defendants privately disclose information about the price adjustment of a stock option to selected market participants before that information is made publicly available, the doctrine of regulatory immunity does not apply." Platinum Partners , 2012 IL App (1st) 112903 , ¶ 2, 364 Ill.Dec. 137 , 976 N.E.2d 415 .

¶ 3 In addition, we found that the trial court had erred in dismissing plaintiffs' complaint pursuant to section 2-615 of the Code of Civil Procedure ( 735 ILCS 5/2-615 (West 2010) ), because the complaint had stated multiple causes of action. Platinum Partners , 2012 IL App (1st) 112903 , ¶ 30, 364 Ill.Dec. 137 , 976 N.E.2d 415 . This court found that plaintiffs had sufficiently pled a cause of action against both defendants with respect to all of their claims: (1) violation of the antifraud provision in section 12(F) of the Illinois Securities Law of 1953 ( 815 ILCS 5/12(F) (West 2002) ); (2) violation of the antifraud provision in section 12(I) of the Illinois Securities Law of 1953 ( 815 ILCS 5/12(I) (West 2002) ); (3) violation of the Illinois Consumer Fraud and Deceptive Business Practices Act ( 815 ILCS 505/10a(a) (West 2002) ); and (4) common law fraud. Platinum Partners , 2012 IL App (1st) 112903 , ¶¶ 21, 26-29, 364 Ill.Dec. 137 , 976 N.E.2d 415 .

¶ 4 After this court remanded the case to the trial court, the trial court subsequently granted summary judgment to defendant *164 OCC on the sole ground of regulatory immunity. The trial court stated that it "need not reach the merits of Plaintiffs' claims against OCC. Instead of determining whether Plaintiffs have proven their causes of action, this Court instead holds that the doctrine of regulatory immunity precludes liability for any cause of actions based on OCC's activities." Platinum Partners Value Arbitrage Fund v. Chicago Board Options Exchange, Inc. , No. 10-CH-54472 (Cir. Ct. Cook County Dec. 20, 2016).

¶ 5 On appeal, plaintiffs claim that the trial court disregarded this court's prior opinion in this case and erred in finding that defendant OCC's conduct in this case was entitled to regulatory immunity. For the following reasons, we reverse and remand for further proceedings.

¶ 6 BACKGROUND

¶ 7 I. Undisputed Facts and Our Prior Opinion

¶ 8 The following facts are not in dispute. Plaintiffs are Cayman Islands investment funds. Plaintiffs invested in options for shares of the India Fund, Inc. (IFN), a fund that invests in the stock of companies located in India. IFN options were traded by defendant CBOE, and defendant OCC cleared and settled the trades. At issue in the case at bar is plaintiff's investment in "put" options that gave it the right to "put" or sell IFN shares to an option seller at a predetermined price, called the "strike price." The value of the option depended on how much more the strike price was than the regular price of IFN shares.

¶ 9 On Friday, December 17, 2010, plaintiff held approximately 25,000 IFN options. After the market closed on December 17, 2010, IFN announced a capital gains distribution to its shareholders of $3.78 per share. The rules of defendants CBOE and OCC permit an adjustment to the strike price of options to account for such a distribution. To account for the negative impact that a distribution of a corporation's assets generally has on the value of its stock, an option's strike price may be adjusted downward. Defendant OCC's published guidelines state that adjustments are made on a "case by case basis."

¶ 10 On Monday, December 20, 2010, plaintiff purchased more than 50,000 additional put options for IFN stock. During the afternoon of December 20, 2010, defendants CBOE and OCC publicly announced a downward adjustment of $3.78 to the strike price of IFN options, resulting in a loss to plaintiffs. The events preceding this public announcement are the subject of this lawsuit.

¶ 11 In essence, defendant argues on appeal primarily that plaintiffs should have known that the strike price would be adjusted and that other investors already knew, while plaintiffs argue that, although an adjustment was permitted, it was not required, and that defendant OCC privately disseminated news of the adjustment to a few investors prior to the public announcement. Thus, defendant points to documents suggesting that plaintiffs should have known, while plaintiffs point to documents showing that defendant privately disseminated information.

¶ 12 However, as we discuss below, 1 whether or not plaintiffs should have known has no impact on the question of whether defendant's acts, if any, of private dissemination are entitled to regulatory immunity.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Platinum Partners Value Arbitrage Fund, Ltd. Partnership v. Chicago Board Options Exchange
2018 IL App (1st) 171316 (Appellate Court of Illinois, 2018)

Cite This Page — Counsel Stack

Bluebook (online)
2018 IL App (1st) 171316, 105 N.E.3d 160, Counsel Stack Legal Research, https://law.counselstack.com/opinion/platinum-partners-value-arbitrage-fund-ltd-partnership-v-chicago-board-illappct-2018.